The Europe CRISPR & Cas genes market, valued at USD 1.35 billion in 2024, is poised for significant expansion, with projections indicating a growth trajectory to USD 7.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of 18.4% from 2025 to 2034. This robust growth is underpinned by a confluence of factors, including substantial government and European Union (EU) research...
Deutsch 
English
Arabic
French
Spanish
Portuguese
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek